V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280012013 | 280011937 | 1.74 | 92 | Palliative (P) | 2018-09-14 | 2018-09-14 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 280029101 | CETUXIMAB + CISPLATIN + FU |
| 280012014 | 280006103 | 1.6 | null | Curative (C) | null | 2017-07-25 | Oxaliplatin + Modified de Gramont | Y | null | 280029119 | OXALIPLATIN + MDG |
| 280012015 | 280006175 | 1.75 | 62 | Neo-adjuvant (N) | 2017-12-12 | 2017-12-18 | DABRAFENIB | N | N | 280029421 | CVP R |
| 280012016 | 280006196 | null | 80.7 | Palliative (P) | null | 2019-03-06 | VINCRISTINE | N | null | 280029471 | VINCRISTINE |
| 280012017 | 280006214 | 1.8 | null | Palliative (P) | null | 2017-12-16 | Cisplatin + Docetaxel | N | null | 280029556 | METHOTREXATE |
| 280012018 | 280006219 | null | 75.6 | Palliative (P) | 2015-02-22 | 2015-02-22 | BEP 3 day | N | N | 280029560 | IFOSFAMIDE + VINCRISTINE |
| 280012019 | 280006284 | 1.57 | 100.8 | Palliative (P) | 2017-08-17 | 2017-08-18 | Cisplatin + Fluorouracil + RT 5day | N | null | 280029782 | IDELALISIB |
| 280012020 | 280006322 | null | 44 | Palliative (P) | 2020-01-27 | 2020-02-01 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | 280029958 | CARBOPLATIN + CETUXIMAB + FU |
| 280012021 | 280006326 | 1.86 | 61.3 | Palliative (P) | 2016-12-18 | 2017-12-15 | Capecitabine + Cisplatin | 02 | N | 280029968 | KESTREL TRIAL |
| 280012022 | 280009318 | 1.6 | 75 | Palliative (P) | 2014-09-10 | 2014-10-12 | Capecitabine + Oxaliplatin 21day | N | N | 280030003 | LIPOSOMAL DOXORUBICIN |
| 280012023 | 280006351 | 1.72 | 95.599 | Curative (C) | 2020-03-08 | 2020-03-29 | CISPLATIN + FLUOROURACIL + RT | 02 | N | 280030055 | NIVOLUMAB |
| 280012025 | 280010757 | 1.61 | 67 | Palliative (P) | 2019-12-02 | 2019-12-09 | BCG Intravesical | 02 | N | 280030165 | IPILIMUMAB |
| 280012026 | 280006423 | 1.65 | 90 | Palliative (P) | null | 2014-06-08 | Cyclophosphamide + Topotecan | 02 | N | 280030215 | IMATINIB |
| 280012027 | 280006441 | 1.7 | 62 | Palliative (P) | 2018-11-18 | 2019-01-04 | CARBOPLATIN + FLUOROURACIL | Y | N | 280030268 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 280012028 | 280006480 | 1.7 | 75.6 | Palliative (P) | 2019-07-24 | 2019-08-09 | Docetaxel 100mg/m2 (21 day) | null | null | 280030373 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280012029 | 280006510 | 1.66 | 57.3 | Palliative (P) | 2013-07-29 | 2014-05-31 | TRASTUZUMAB | N | N | 280030483 | BUSULFAN + MELPHALAN |
| 280012030 | 280012086 | null | 82.7 | Palliative (P) | null | 2018-06-10 | EVEROLIMUS + EXEMESTANE | 2 | N | 280030581 | IPILIMUMAB + NIVOLUMAB |
| 280012031 | 280006574 | 1.57 | 79.8 | Palliative (P) | 2019-04-02 | 2019-04-08 | CARBOPLATIN + FLUOROURACIL | N | N | 280030705 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280012032 | 280006623 | 1.85 | 79.4 | Palliative (P) | 2016-04-14 | 2016-04-24 | LIPOSOMAL DOXORUBICIN | Y | N | 280018042 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 280012033 | 280006630 | 1.83 | 66.4 | Palliative (P) | null | 2019-02-18 | ETOPOSIDE | null | null | 280019073 | NIVOLUMAB |
| 280012034 | 280009456 | 1.73 | 61 | Disease modification (D) | 2016-07-23 | 2016-07-23 | Hydroxycarbamide | N | N | 280020096 | VINCRISTINE |
| 280012035 | 280009462 | 1.62 | 100.5 | Neo-adjuvant (N) | 2017-03-24 | 2018-11-26 | Y-90 | N | N | 280020669 | VIA |
| 280012036 | 280006713 | 1.67 | 60.8 | Curative (C) | null | 2015-10-12 | CTD | N | N | 280023280 | LIPOSOMAL DOXORUBICIN |
| 280012037 | 280010840 | 1.62 | 52 | Curative (C) | 2020-01-28 | 2020-02-07 | PEMBROLIZUMAB | N | N | 280026551 | VINORELBINE |
| 280012039 | 280004264 | null | 66.6 | Palliative (P) | 2017-03-20 | 2017-04-18 | Trial Unspecified | 02 | Y | 280007383 | TRIAL |
| 280012040 | 280008353 | 1.76 | 55.7 | Palliative (P) | 2014-11-19 | 2014-11-22 | Trabectedin | N | N | 280011597 | TRABECTEDIN |
| 280012041 | 280004708 | 1.76 | null | Curative (C) | 2017-06-13 | 2017-06-28 | CISPLATIN + RT | 2 | N | 280024610 | CISPLATIN + RT |
| 280012042 | 280011650 | null | 96.6 | Curative (C) | 2015-07-22 | 2015-08-04 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | 280024659 | CISPLATIN + RT |
| 280012043 | 280004789 | 1.73 | null | Curative (C) | 2017-03-11 | 2017-04-11 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 280024821 | CISPLATIN + RT |
| 280012044 | 280004795 | 0 | 104.9 | Palliative (P) | 2019-02-03 | 2019-03-03 | Trabectedin | 02 | N | 280024836 | TRABECTEDIN |
| 280012045 | 280004824 | 1.61 | 51.8 | Curative (C) | null | 2018-07-20 | Cetuximab 7 day (>Cycle 2) | N | Y | 280024896 | CETUXIMAB |
| 280012046 | 280004840 | null | 64.9 | Palliative (P) | 2015-09-06 | 2015-11-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280024927 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280012047 | 280011227 | null | 78 | Palliative (P) | 2015-12-16 | 2016-01-05 | CETUXIMAB | 02 | N | 280025130 | CETUXIMAB |
| 280012048 | 280010359 | 1.86 | 74.6 | Curative (C) | 2016-07-09 | 2016-07-09 | STS Rhabdo RMS 2005 2nd Etop Carbo | N | Y | 280025171 | NOT MATCHED |
| 280012049 | 280004939 | 1.71 | 85.9 | Palliative (P) | 2013-12-02 | 2014-03-10 | CARBOPLATIN | 02 | N | 280025187 | CARBOPLATIN |
| 280012050 | 280005103 | null | 90 | Curative (C) | 2017-02-07 | 2017-03-23 | CISPLATIN + DOCETAXEL + FLUOROURACIL | Y | null | 280025588 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280012051 | 280005125 | null | 75.7 | null | 2017-01-17 | 2017-06-19 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + DOXORUBICIN + VINCRISTINE | N | null | 280025635 | NOT MATCHED |
| 280012052 | 280008715 | 1.77 | 68 | Palliative (P) | 2014-10-20 | 2014-10-20 | Docetaxel + Gemcitabine with GCSF | N | N | 280025647 | DOCETAXEL + GEMCITABINE |
| 280012053 | 280005180 | 1.54 | 107 | Palliative (P) | 2017-06-15 | 2017-12-08 | Olaratumab | null | null | 280025794 | NOT MATCHED |
| 280012054 | 280008757 | 1.78 | 11.5 | null | 2014-07-24 | 2014-08-11 | Carboplatin AUC 6 - 10 | N | N | 280025900 | CARBOPLATIN |
| 280012055 | 280005347 | 1.84 | 0 | Palliative (P) | 2018-07-09 | 2018-07-09 | CETUXIMAB | 02 | N | 280026313 | CETUXIMAB |
| 280012056 | 280005414 | 1.85 | 113.8 | Palliative (P) | 2014-11-29 | 2015-03-12 | NB HRNBL-1 COJEC Ind COURSE B | Y | N | 280026704 | NOT MATCHED |
| 280012057 | 280005438 | 1.7 | 76 | Palliative (P) | 2015-12-01 | 2015-12-01 | Docetaxel + Gemcitabine (prior RT) | N | N | 280026803 | DOCETAXEL + GEMCITABINE |
| 280012058 | 280005627 | null | 63.75 | Palliative (P) | 2017-05-19 | 2017-05-26 | CETUXIMAB | null | null | 280027573 | CETUXIMAB |
| 280012059 | 280005700 | null | 80.2 | Adjuvant (A) | 2015-04-20 | 2015-07-17 | IVA | 02 | N | 280027817 | IVA |
| 280012060 | 280005704 | 1.5 | 41.2 | Palliative (P) | null | 2019-07-08 | DOXORUBICIN | 02 | N | 280027822 | DOXORUBICIN |
| 280012061 | 280005760 | 1.59 | null | Palliative (P) | null | 2020-03-13 | CETUXIMAB + RT | null | null | 280028006 | CETUXIMAB + RT |
| 280012062 | 280009040 | 1.91 | null | Palliative (P) | null | 2015-09-24 | Doxorubicin 75mg/m2 | Y | N | 280028146 | DOXORUBICIN |
| 280012063 | 280005820 | 1.45 | 62.5 | Neo-adjuvant (N) | 2015-11-24 | 2015-11-30 | DOXORUBICIN | N | N | 280028183 | DOXORUBICIN |
| 280012064 | 280005843 | null | 100 | Curative (C) | 2016-08-06 | 2016-08-19 | CARBOPLATIN + RT | N | Y | 280028259 | CARBOPLATIN + RT |